Companies: 10,795·Total market cap: $144.5T
Applied Genetic Technologies Corporation

Applied Genetic Technologies Corporation

AGTCNASDAQHealthcare
$0.39
+$0.00(+0.00%)
Market Cap$0
P/E Ratio—
52W High$2.825
52W Low$0.2303
SEC Filings

Applied Genetic Technologies Corporation (AGTC) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001273636 · AGTC · NASDAQ · as of Jun 9, 2026

Filing snapshot

569
Total Filings
SC 13G/A
Latest Form
2023-02-14
Most Recent
2014
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001273636 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2022-10-24
Fiscal Year End
Oct 24, 2022
Accession No.
0001193125-22-267593
Primary Document
d371262d10ka.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001273636 · Accession 0001193125-22-267593

Latest Key Filings

10-QQuarterly Report
10-Q
2022-11-21
View 10-Q on SEC
8-KCurrent Report
8-K
2022-12-01Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
SC 13G/ABeneficial Ownership Report (Amended)
Beneficial Ownership Report (Amended)
2023-02-14
View
15-12G15-12G
15-12G
2022-12-12
View
SC 13DActivist Ownership Report
APPLIED GENETIC TECHNOLOGIES CORPORATION
2022-12-08
View
EFFECTEFFECT
EFFECT
2022-12-06
View
EFFECTEFFECT
EFFECT
2022-12-06
View
EFFECTEFFECT
EFFECT
2022-12-06
View
25-NSE25-NSE
25-NSE
2022-12-01
View
S-8 POSS-8 POS
S-8 POS
2022-12-01
View
S-8 POSS-8 POS
S-8 POS
2022-12-01
View
S-8 POSS-8 POS
S-8 POS
2022-12-01
View
S-8 POSS-8 POS
S-8 POS
2022-12-01
View
S-8 POSS-8 POS
S-8 POS
2022-12-01
View
POS AMPOS AM
POS AM
2022-12-01
View
POS AMPOS AM
POS AM
2022-12-01
View
POS AMPOS AM
POS AM
2022-12-01
View
Showing 1–15 of 365 filingsForm 4 / 144 hidden· 569 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001273636  |  Exchange: NASDAQ · Healthcare

Applied Genetic Technologies Corporation (NASDAQ: AGTC) has submitted 569 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2014. As a Healthcare sector company with CIK 0001273636, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Applied Genetic Technologies Corporation's most comprehensive regulatory disclosure. The most recent Applied Genetic Technologies Corporation 10-K was filed on 2022-10-24 for fiscal year ending 2022. Historical AGTC 10-K annual reports are available from 2003 through 2022.

Investors researching Applied Genetic Technologies Corporation SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
HARP SEC Filings →MRNS SEC Filings →ANGN SEC Filings →ALLK SEC Filings →FRLN SEC Filings →ELEV SEC Filings →SER SEC Filings →AXLA SEC Filings →
→ AGTC Financials→ AGTC Earnings→ AGTC Insider Trades

Frequently Asked Questions

AGTC SEC Filings · 8 questions

Applied Genetic Technologies Corporation (AGTC) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 569 filings and access original documents at no cost. Applied Genetic Technologies Corporation's CIK is 0001273636.

AGTC SEC filingsApplied Genetic Technologies Corporation SEC documentsfind AGTC 10-K